Patent disputes are significantly lower since they peaked at 5,874 in 2015. Litigation tumbled 41% to 3,491 cases in 2018, and was down 14% from
Tag: patent litigation
“NPEs generate higher damages awards,” 2017 litigation study finds
The disparity in patent damages awards between non-practicing and practicing entities favors NPEs and is growing wider. These findings, counter-intuitive to some, are part of
China is poised to overtake the U.S. as the leading patent system
A few years ago a company whose patents were violated in China had little or no chance of defending its rights. Determined to move beyond
Gov’t study of economic impact of patent infringement is needed ASAP, experts say
There are abundant statistics on the cost of counterfeit goods, copyright infringement and even the negative impact of patent “trolls,” but nothing on the estimated
Top patent defendants have faced far fewer suits in 2016, so far
The size of businesses sued most frequently for patent infringement in 2016 were significantly larger than in 2015, when five little-known patent holders were among
Reporter: Patent system failed heart valve inventor
One of the biggest obstacle to inventors today may the system created to protect them. Research cardiologist Tory Norred thinks so. In a recent
Raymond P. Niro, pioneering patent litigator, is dead at 73
Raymond Niro, a highly successful patent litigator who represented primarily inventors and other plaintiffs, passed away on August 9 at the age of 73. It
A record number of major holders were granted far fewer US patents
Many significant tech companies experienced dramatic declines in US patent grants, fueling speculation about the reasons why. While total patent grants were virtually flat, according
Financial patent summit to focus on IP and cybersecurity, July 20-21
Fintech, or financial technology, is a rapidly growing industry with more than $15 billion of venture capital invested to date and even more on the
Media use of patent “troll” is unfair says professor in Stanford Technology Law Review
The use of inaccurate, prejudicial language by newspapers, business publications and technology magazines to describe patent licensing activity biases readers and courts. That is among
Validated Merck patents could mean a $3B+ windfall, after appeals
While many high-tech patents are suffering from devaluation the value of some pharmaceutical patents is soaring. Merck & Co. won a legal victory over
“Patent Investor” tracks licensing company shares & developments
A new weekly is the first to feature in-depth coverage of public intellectual property monetization companies (PIPCOs). I’ve been following The Patent Investor for a
